Effects of amorphous silica coating on cerium oxide nanoparticles induced pulmonary responses

Recently cerium compounds have been used in a variety of consumer products, including diesel fuel additives, to increase fuel combustion efficiency and decrease diesel soot emissions. However, cerium oxide (CeO2) nanoparticles have been detected in the exhaust, which raises a health concern. Previou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicology and applied pharmacology 2015-10, Vol.288 (1), p.63-73
Hauptverfasser: Ma, Jane, Mercer, Robert R., Barger, Mark, Schwegler-Berry, Diane, Cohen, Joel M., Demokritou, Philip, Castranova, Vincent
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 73
container_issue 1
container_start_page 63
container_title Toxicology and applied pharmacology
container_volume 288
creator Ma, Jane
Mercer, Robert R.
Barger, Mark
Schwegler-Berry, Diane
Cohen, Joel M.
Demokritou, Philip
Castranova, Vincent
description Recently cerium compounds have been used in a variety of consumer products, including diesel fuel additives, to increase fuel combustion efficiency and decrease diesel soot emissions. However, cerium oxide (CeO2) nanoparticles have been detected in the exhaust, which raises a health concern. Previous studies have shown that exposure of rats to nanoscale CeO2 by intratracheal instillation (IT) induces sustained pulmonary inflammation and fibrosis. In the present study, male Sprague–Dawley rats were exposed to CeO2 or CeO2 coated with a nano layer of amorphous SiO2 (aSiO2/CeO2) by a single IT and sacrificed at various times post-exposure to assess potential protective effects of the aSiO2 coating. The first acellular bronchoalveolar lavage (BAL) fluid and BAL cells were collected and analyzed from all exposed animals. At the low dose (0.15mg/kg), CeO2 but not aSiO2/CeO2 exposure induced inflammation. However, at the higher doses, both particles induced a dose-related inflammation, cytotoxicity, inflammatory cytokines, matrix metalloproteinase (MMP)-9, and tissue inhibitor of MMP at 1day post-exposure. Morphological analysis of lung showed an increased inflammation, surfactant and collagen fibers after CeO2 (high dose at 3.5mg/kg) treatment at 28days post-exposure. aSiO2 coating significantly reduced CeO2-induced inflammatory responses in the airspace and appeared to attenuate phospholipidosis and fibrosis. Energy dispersive X-ray spectroscopy analysis showed Ce and phosphorous (P) in all particle-exposed lungs, whereas Si was only detected in aSiO2/CeO2-exposed lungs up to 3days after exposure, suggesting that aSiO2 dissolved off the CeO2 core, and some of the CeO2 was transformed to CePO4 with time. These results demonstrate that aSiO2 coating reduce CeO2-induced inflammation, phospholipidosis and fibrosis. •Both CeO2 and aSiO2/CeO2 particles were detected in the respective particle-exposed lungs.•The dissolution of aSiO2 coating from CeO2 particle core with time was demonstrated in the particle-exposed lungs.•aSiO2 coating significantly protected CeO2-induced pulmonary inflammatory responses.•aSiO2 coating showed a protective effect on CeO2-induced lung fibrosis.
doi_str_mv 10.1016/j.taap.2015.07.012
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4579046</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041008X15300387</els_id><sourcerecordid>1751206185</sourcerecordid><originalsourceid>FETCH-LOGICAL-c582t-a9a5a5d8759fd5fc65efeed1601660210e0a822d35fda248404aa31b931872443</originalsourceid><addsrcrecordid>eNp9kU9rFTEUxYMo9ln9Ai4k4MbNjDeZJDMDIkipf6DQTQU3EtLkTl8eM8mYzBT77c3watFNV1ncc09-9xxCXjOoGTD1_lAvxsw1ByZraGtg_AnZMehVBU3TPCU7AMEqgO7HCXmR8wEAeiHYc3LCFWfQiH5Hfp4PA9ol0zhQM8U07-Oaafajt4baaBYfbmgM1GLy60Tjb--QBhPibNLi7YiZ-uBWi47O6zjFYNIdTZjnGDLml-TZYMaMr-7fU_L98_nV2dfq4vLLt7NPF5WVHV8q0xtppOta2Q9ODlZJHBAdU-VKBQUVwXScu0YOznDRCRDGNOy6b1jXciGaU_Lx6Duv1xM6i2FJZtRz8lPh0dF4_f8k-L2-ibdayLYHoYrB26NBzIvX2foF7d7GEEo2mnPVta1qi-rd_Tcp_loxL3ry2eI4moAlNs1ayTgo1ski5UepTTHnhMMDDAO9tacPemtPb-1paHVpryy9-feMh5W_dRXBh6MAS5i3HtOGiqGk79NG6qJ_zP8PjnetQg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1751206185</pqid></control><display><type>article</type><title>Effects of amorphous silica coating on cerium oxide nanoparticles induced pulmonary responses</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Ma, Jane ; Mercer, Robert R. ; Barger, Mark ; Schwegler-Berry, Diane ; Cohen, Joel M. ; Demokritou, Philip ; Castranova, Vincent</creator><creatorcontrib>Ma, Jane ; Mercer, Robert R. ; Barger, Mark ; Schwegler-Berry, Diane ; Cohen, Joel M. ; Demokritou, Philip ; Castranova, Vincent</creatorcontrib><description>Recently cerium compounds have been used in a variety of consumer products, including diesel fuel additives, to increase fuel combustion efficiency and decrease diesel soot emissions. However, cerium oxide (CeO2) nanoparticles have been detected in the exhaust, which raises a health concern. Previous studies have shown that exposure of rats to nanoscale CeO2 by intratracheal instillation (IT) induces sustained pulmonary inflammation and fibrosis. In the present study, male Sprague–Dawley rats were exposed to CeO2 or CeO2 coated with a nano layer of amorphous SiO2 (aSiO2/CeO2) by a single IT and sacrificed at various times post-exposure to assess potential protective effects of the aSiO2 coating. The first acellular bronchoalveolar lavage (BAL) fluid and BAL cells were collected and analyzed from all exposed animals. At the low dose (0.15mg/kg), CeO2 but not aSiO2/CeO2 exposure induced inflammation. However, at the higher doses, both particles induced a dose-related inflammation, cytotoxicity, inflammatory cytokines, matrix metalloproteinase (MMP)-9, and tissue inhibitor of MMP at 1day post-exposure. Morphological analysis of lung showed an increased inflammation, surfactant and collagen fibers after CeO2 (high dose at 3.5mg/kg) treatment at 28days post-exposure. aSiO2 coating significantly reduced CeO2-induced inflammatory responses in the airspace and appeared to attenuate phospholipidosis and fibrosis. Energy dispersive X-ray spectroscopy analysis showed Ce and phosphorous (P) in all particle-exposed lungs, whereas Si was only detected in aSiO2/CeO2-exposed lungs up to 3days after exposure, suggesting that aSiO2 dissolved off the CeO2 core, and some of the CeO2 was transformed to CePO4 with time. These results demonstrate that aSiO2 coating reduce CeO2-induced inflammation, phospholipidosis and fibrosis. •Both CeO2 and aSiO2/CeO2 particles were detected in the respective particle-exposed lungs.•The dissolution of aSiO2 coating from CeO2 particle core with time was demonstrated in the particle-exposed lungs.•aSiO2 coating significantly protected CeO2-induced pulmonary inflammatory responses.•aSiO2 coating showed a protective effect on CeO2-induced lung fibrosis.</description><identifier>ISSN: 0041-008X</identifier><identifier>EISSN: 1096-0333</identifier><identifier>DOI: 10.1016/j.taap.2015.07.012</identifier><identifier>PMID: 26210349</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>60 APPLIED LIFE SCIENCES ; ANIMAL TISSUES ; Animals ; Anti-Inflammatory Agents - chemistry ; Anti-Inflammatory Agents - pharmacology ; Bronchoalveolar Lavage Fluid - chemistry ; CERIUM ; Cerium - chemistry ; Cerium - toxicity ; Cerium oxide, amorphous silica ; CERIUM OXIDES ; CERIUM PHOSPHATES ; COLLAGEN ; Collagen - metabolism ; COMBUSTION ; CONSUMER PRODUCTS ; Cytokines - metabolism ; Cytoprotection ; DIESEL FUELS ; Dose-Response Relationship, Drug ; FIBROSIS ; FUEL ADDITIVES ; INFLAMMATION ; Inflammation Mediators - metabolism ; Lung - drug effects ; Lung - metabolism ; Lung - pathology ; Lung inflammation ; LUNGS ; LYMPHOKINES ; Male ; Matrix Metalloproteinase 9 - metabolism ; Metal Nanoparticles - chemistry ; Metal Nanoparticles - toxicity ; NANOPARTICLES ; Phospholipids - metabolism ; Pneumonia - chemically induced ; Pneumonia - metabolism ; Pneumonia - pathology ; Pneumonia - prevention &amp; control ; Pulmonary fibrosis ; Pulmonary Fibrosis - chemically induced ; Pulmonary Fibrosis - metabolism ; Pulmonary Fibrosis - pathology ; Pulmonary Fibrosis - prevention &amp; control ; Pulmonary Surfactant-Associated Proteins - metabolism ; RATS ; Rats, Sprague-Dawley ; Safer by design ; SILICA ; Silicon Dioxide - chemistry ; Silicon Dioxide - pharmacology ; SILICON OXIDES ; SOOT ; Spectrometry, X-Ray Emission ; Surface Properties ; Time Factors ; Tissue Inhibitor of Metalloproteinases - metabolism ; X-RAY SPECTROSCOPY</subject><ispartof>Toxicology and applied pharmacology, 2015-10, Vol.288 (1), p.63-73</ispartof><rights>2015</rights><rights>Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c582t-a9a5a5d8759fd5fc65efeed1601660210e0a822d35fda248404aa31b931872443</citedby><cites>FETCH-LOGICAL-c582t-a9a5a5d8759fd5fc65efeed1601660210e0a822d35fda248404aa31b931872443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.taap.2015.07.012$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26210349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/22687767$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Ma, Jane</creatorcontrib><creatorcontrib>Mercer, Robert R.</creatorcontrib><creatorcontrib>Barger, Mark</creatorcontrib><creatorcontrib>Schwegler-Berry, Diane</creatorcontrib><creatorcontrib>Cohen, Joel M.</creatorcontrib><creatorcontrib>Demokritou, Philip</creatorcontrib><creatorcontrib>Castranova, Vincent</creatorcontrib><title>Effects of amorphous silica coating on cerium oxide nanoparticles induced pulmonary responses</title><title>Toxicology and applied pharmacology</title><addtitle>Toxicol Appl Pharmacol</addtitle><description>Recently cerium compounds have been used in a variety of consumer products, including diesel fuel additives, to increase fuel combustion efficiency and decrease diesel soot emissions. However, cerium oxide (CeO2) nanoparticles have been detected in the exhaust, which raises a health concern. Previous studies have shown that exposure of rats to nanoscale CeO2 by intratracheal instillation (IT) induces sustained pulmonary inflammation and fibrosis. In the present study, male Sprague–Dawley rats were exposed to CeO2 or CeO2 coated with a nano layer of amorphous SiO2 (aSiO2/CeO2) by a single IT and sacrificed at various times post-exposure to assess potential protective effects of the aSiO2 coating. The first acellular bronchoalveolar lavage (BAL) fluid and BAL cells were collected and analyzed from all exposed animals. At the low dose (0.15mg/kg), CeO2 but not aSiO2/CeO2 exposure induced inflammation. However, at the higher doses, both particles induced a dose-related inflammation, cytotoxicity, inflammatory cytokines, matrix metalloproteinase (MMP)-9, and tissue inhibitor of MMP at 1day post-exposure. Morphological analysis of lung showed an increased inflammation, surfactant and collagen fibers after CeO2 (high dose at 3.5mg/kg) treatment at 28days post-exposure. aSiO2 coating significantly reduced CeO2-induced inflammatory responses in the airspace and appeared to attenuate phospholipidosis and fibrosis. Energy dispersive X-ray spectroscopy analysis showed Ce and phosphorous (P) in all particle-exposed lungs, whereas Si was only detected in aSiO2/CeO2-exposed lungs up to 3days after exposure, suggesting that aSiO2 dissolved off the CeO2 core, and some of the CeO2 was transformed to CePO4 with time. These results demonstrate that aSiO2 coating reduce CeO2-induced inflammation, phospholipidosis and fibrosis. •Both CeO2 and aSiO2/CeO2 particles were detected in the respective particle-exposed lungs.•The dissolution of aSiO2 coating from CeO2 particle core with time was demonstrated in the particle-exposed lungs.•aSiO2 coating significantly protected CeO2-induced pulmonary inflammatory responses.•aSiO2 coating showed a protective effect on CeO2-induced lung fibrosis.</description><subject>60 APPLIED LIFE SCIENCES</subject><subject>ANIMAL TISSUES</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - chemistry</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Bronchoalveolar Lavage Fluid - chemistry</subject><subject>CERIUM</subject><subject>Cerium - chemistry</subject><subject>Cerium - toxicity</subject><subject>Cerium oxide, amorphous silica</subject><subject>CERIUM OXIDES</subject><subject>CERIUM PHOSPHATES</subject><subject>COLLAGEN</subject><subject>Collagen - metabolism</subject><subject>COMBUSTION</subject><subject>CONSUMER PRODUCTS</subject><subject>Cytokines - metabolism</subject><subject>Cytoprotection</subject><subject>DIESEL FUELS</subject><subject>Dose-Response Relationship, Drug</subject><subject>FIBROSIS</subject><subject>FUEL ADDITIVES</subject><subject>INFLAMMATION</subject><subject>Inflammation Mediators - metabolism</subject><subject>Lung - drug effects</subject><subject>Lung - metabolism</subject><subject>Lung - pathology</subject><subject>Lung inflammation</subject><subject>LUNGS</subject><subject>LYMPHOKINES</subject><subject>Male</subject><subject>Matrix Metalloproteinase 9 - metabolism</subject><subject>Metal Nanoparticles - chemistry</subject><subject>Metal Nanoparticles - toxicity</subject><subject>NANOPARTICLES</subject><subject>Phospholipids - metabolism</subject><subject>Pneumonia - chemically induced</subject><subject>Pneumonia - metabolism</subject><subject>Pneumonia - pathology</subject><subject>Pneumonia - prevention &amp; control</subject><subject>Pulmonary fibrosis</subject><subject>Pulmonary Fibrosis - chemically induced</subject><subject>Pulmonary Fibrosis - metabolism</subject><subject>Pulmonary Fibrosis - pathology</subject><subject>Pulmonary Fibrosis - prevention &amp; control</subject><subject>Pulmonary Surfactant-Associated Proteins - metabolism</subject><subject>RATS</subject><subject>Rats, Sprague-Dawley</subject><subject>Safer by design</subject><subject>SILICA</subject><subject>Silicon Dioxide - chemistry</subject><subject>Silicon Dioxide - pharmacology</subject><subject>SILICON OXIDES</subject><subject>SOOT</subject><subject>Spectrometry, X-Ray Emission</subject><subject>Surface Properties</subject><subject>Time Factors</subject><subject>Tissue Inhibitor of Metalloproteinases - metabolism</subject><subject>X-RAY SPECTROSCOPY</subject><issn>0041-008X</issn><issn>1096-0333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9rFTEUxYMo9ln9Ai4k4MbNjDeZJDMDIkipf6DQTQU3EtLkTl8eM8mYzBT77c3watFNV1ncc09-9xxCXjOoGTD1_lAvxsw1ByZraGtg_AnZMehVBU3TPCU7AMEqgO7HCXmR8wEAeiHYc3LCFWfQiH5Hfp4PA9ol0zhQM8U07-Oaafajt4baaBYfbmgM1GLy60Tjb--QBhPibNLi7YiZ-uBWi47O6zjFYNIdTZjnGDLml-TZYMaMr-7fU_L98_nV2dfq4vLLt7NPF5WVHV8q0xtppOta2Q9ODlZJHBAdU-VKBQUVwXScu0YOznDRCRDGNOy6b1jXciGaU_Lx6Duv1xM6i2FJZtRz8lPh0dF4_f8k-L2-ibdayLYHoYrB26NBzIvX2foF7d7GEEo2mnPVta1qi-rd_Tcp_loxL3ry2eI4moAlNs1ayTgo1ski5UepTTHnhMMDDAO9tacPemtPb-1paHVpryy9-feMh5W_dRXBh6MAS5i3HtOGiqGk79NG6qJ_zP8PjnetQg</recordid><startdate>20151001</startdate><enddate>20151001</enddate><creator>Ma, Jane</creator><creator>Mercer, Robert R.</creator><creator>Barger, Mark</creator><creator>Schwegler-Berry, Diane</creator><creator>Cohen, Joel M.</creator><creator>Demokritou, Philip</creator><creator>Castranova, Vincent</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>OTOTI</scope><scope>5PM</scope></search><sort><creationdate>20151001</creationdate><title>Effects of amorphous silica coating on cerium oxide nanoparticles induced pulmonary responses</title><author>Ma, Jane ; Mercer, Robert R. ; Barger, Mark ; Schwegler-Berry, Diane ; Cohen, Joel M. ; Demokritou, Philip ; Castranova, Vincent</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c582t-a9a5a5d8759fd5fc65efeed1601660210e0a822d35fda248404aa31b931872443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>60 APPLIED LIFE SCIENCES</topic><topic>ANIMAL TISSUES</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - chemistry</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Bronchoalveolar Lavage Fluid - chemistry</topic><topic>CERIUM</topic><topic>Cerium - chemistry</topic><topic>Cerium - toxicity</topic><topic>Cerium oxide, amorphous silica</topic><topic>CERIUM OXIDES</topic><topic>CERIUM PHOSPHATES</topic><topic>COLLAGEN</topic><topic>Collagen - metabolism</topic><topic>COMBUSTION</topic><topic>CONSUMER PRODUCTS</topic><topic>Cytokines - metabolism</topic><topic>Cytoprotection</topic><topic>DIESEL FUELS</topic><topic>Dose-Response Relationship, Drug</topic><topic>FIBROSIS</topic><topic>FUEL ADDITIVES</topic><topic>INFLAMMATION</topic><topic>Inflammation Mediators - metabolism</topic><topic>Lung - drug effects</topic><topic>Lung - metabolism</topic><topic>Lung - pathology</topic><topic>Lung inflammation</topic><topic>LUNGS</topic><topic>LYMPHOKINES</topic><topic>Male</topic><topic>Matrix Metalloproteinase 9 - metabolism</topic><topic>Metal Nanoparticles - chemistry</topic><topic>Metal Nanoparticles - toxicity</topic><topic>NANOPARTICLES</topic><topic>Phospholipids - metabolism</topic><topic>Pneumonia - chemically induced</topic><topic>Pneumonia - metabolism</topic><topic>Pneumonia - pathology</topic><topic>Pneumonia - prevention &amp; control</topic><topic>Pulmonary fibrosis</topic><topic>Pulmonary Fibrosis - chemically induced</topic><topic>Pulmonary Fibrosis - metabolism</topic><topic>Pulmonary Fibrosis - pathology</topic><topic>Pulmonary Fibrosis - prevention &amp; control</topic><topic>Pulmonary Surfactant-Associated Proteins - metabolism</topic><topic>RATS</topic><topic>Rats, Sprague-Dawley</topic><topic>Safer by design</topic><topic>SILICA</topic><topic>Silicon Dioxide - chemistry</topic><topic>Silicon Dioxide - pharmacology</topic><topic>SILICON OXIDES</topic><topic>SOOT</topic><topic>Spectrometry, X-Ray Emission</topic><topic>Surface Properties</topic><topic>Time Factors</topic><topic>Tissue Inhibitor of Metalloproteinases - metabolism</topic><topic>X-RAY SPECTROSCOPY</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ma, Jane</creatorcontrib><creatorcontrib>Mercer, Robert R.</creatorcontrib><creatorcontrib>Barger, Mark</creatorcontrib><creatorcontrib>Schwegler-Berry, Diane</creatorcontrib><creatorcontrib>Cohen, Joel M.</creatorcontrib><creatorcontrib>Demokritou, Philip</creatorcontrib><creatorcontrib>Castranova, Vincent</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>OSTI.GOV</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Toxicology and applied pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ma, Jane</au><au>Mercer, Robert R.</au><au>Barger, Mark</au><au>Schwegler-Berry, Diane</au><au>Cohen, Joel M.</au><au>Demokritou, Philip</au><au>Castranova, Vincent</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of amorphous silica coating on cerium oxide nanoparticles induced pulmonary responses</atitle><jtitle>Toxicology and applied pharmacology</jtitle><addtitle>Toxicol Appl Pharmacol</addtitle><date>2015-10-01</date><risdate>2015</risdate><volume>288</volume><issue>1</issue><spage>63</spage><epage>73</epage><pages>63-73</pages><issn>0041-008X</issn><eissn>1096-0333</eissn><abstract>Recently cerium compounds have been used in a variety of consumer products, including diesel fuel additives, to increase fuel combustion efficiency and decrease diesel soot emissions. However, cerium oxide (CeO2) nanoparticles have been detected in the exhaust, which raises a health concern. Previous studies have shown that exposure of rats to nanoscale CeO2 by intratracheal instillation (IT) induces sustained pulmonary inflammation and fibrosis. In the present study, male Sprague–Dawley rats were exposed to CeO2 or CeO2 coated with a nano layer of amorphous SiO2 (aSiO2/CeO2) by a single IT and sacrificed at various times post-exposure to assess potential protective effects of the aSiO2 coating. The first acellular bronchoalveolar lavage (BAL) fluid and BAL cells were collected and analyzed from all exposed animals. At the low dose (0.15mg/kg), CeO2 but not aSiO2/CeO2 exposure induced inflammation. However, at the higher doses, both particles induced a dose-related inflammation, cytotoxicity, inflammatory cytokines, matrix metalloproteinase (MMP)-9, and tissue inhibitor of MMP at 1day post-exposure. Morphological analysis of lung showed an increased inflammation, surfactant and collagen fibers after CeO2 (high dose at 3.5mg/kg) treatment at 28days post-exposure. aSiO2 coating significantly reduced CeO2-induced inflammatory responses in the airspace and appeared to attenuate phospholipidosis and fibrosis. Energy dispersive X-ray spectroscopy analysis showed Ce and phosphorous (P) in all particle-exposed lungs, whereas Si was only detected in aSiO2/CeO2-exposed lungs up to 3days after exposure, suggesting that aSiO2 dissolved off the CeO2 core, and some of the CeO2 was transformed to CePO4 with time. These results demonstrate that aSiO2 coating reduce CeO2-induced inflammation, phospholipidosis and fibrosis. •Both CeO2 and aSiO2/CeO2 particles were detected in the respective particle-exposed lungs.•The dissolution of aSiO2 coating from CeO2 particle core with time was demonstrated in the particle-exposed lungs.•aSiO2 coating significantly protected CeO2-induced pulmonary inflammatory responses.•aSiO2 coating showed a protective effect on CeO2-induced lung fibrosis.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26210349</pmid><doi>10.1016/j.taap.2015.07.012</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0041-008X
ispartof Toxicology and applied pharmacology, 2015-10, Vol.288 (1), p.63-73
issn 0041-008X
1096-0333
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4579046
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects 60 APPLIED LIFE SCIENCES
ANIMAL TISSUES
Animals
Anti-Inflammatory Agents - chemistry
Anti-Inflammatory Agents - pharmacology
Bronchoalveolar Lavage Fluid - chemistry
CERIUM
Cerium - chemistry
Cerium - toxicity
Cerium oxide, amorphous silica
CERIUM OXIDES
CERIUM PHOSPHATES
COLLAGEN
Collagen - metabolism
COMBUSTION
CONSUMER PRODUCTS
Cytokines - metabolism
Cytoprotection
DIESEL FUELS
Dose-Response Relationship, Drug
FIBROSIS
FUEL ADDITIVES
INFLAMMATION
Inflammation Mediators - metabolism
Lung - drug effects
Lung - metabolism
Lung - pathology
Lung inflammation
LUNGS
LYMPHOKINES
Male
Matrix Metalloproteinase 9 - metabolism
Metal Nanoparticles - chemistry
Metal Nanoparticles - toxicity
NANOPARTICLES
Phospholipids - metabolism
Pneumonia - chemically induced
Pneumonia - metabolism
Pneumonia - pathology
Pneumonia - prevention & control
Pulmonary fibrosis
Pulmonary Fibrosis - chemically induced
Pulmonary Fibrosis - metabolism
Pulmonary Fibrosis - pathology
Pulmonary Fibrosis - prevention & control
Pulmonary Surfactant-Associated Proteins - metabolism
RATS
Rats, Sprague-Dawley
Safer by design
SILICA
Silicon Dioxide - chemistry
Silicon Dioxide - pharmacology
SILICON OXIDES
SOOT
Spectrometry, X-Ray Emission
Surface Properties
Time Factors
Tissue Inhibitor of Metalloproteinases - metabolism
X-RAY SPECTROSCOPY
title Effects of amorphous silica coating on cerium oxide nanoparticles induced pulmonary responses
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T20%3A54%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20amorphous%20silica%20coating%20on%20cerium%20oxide%20nanoparticles%20induced%20pulmonary%20responses&rft.jtitle=Toxicology%20and%20applied%20pharmacology&rft.au=Ma,%20Jane&rft.date=2015-10-01&rft.volume=288&rft.issue=1&rft.spage=63&rft.epage=73&rft.pages=63-73&rft.issn=0041-008X&rft.eissn=1096-0333&rft_id=info:doi/10.1016/j.taap.2015.07.012&rft_dat=%3Cproquest_pubme%3E1751206185%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1751206185&rft_id=info:pmid/26210349&rft_els_id=S0041008X15300387&rfr_iscdi=true